PRIVIGEN 100 MG/ML FV 25 ML
(Immunoglobuline humaine normale [plasmatique]) - Maladie rare sans désignation orpheline
* Replacement therapy in adults, and children and adolescents (0-18 years) in:
- Primary immunodeficiency (PID) syndromes with impaired antibody production,
- Hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic leukaemia, in whom prophylactic antibiotics have failed,
- Hypogammaglobulinaemia and recurrent bacterial infections in plateau phase multiple myeloma patients who have failed to respond to pneumococcal immunization,
- Hypogammaglobulinaemia in patients after allogeneic haematopoietic stem cell transplantation (HSCT),
- Congenital AIDS with recurrent bacterial infections.
* Immunomodulation in adults, and children and adolescents (0-18 years) in:
- Primary immune thrombocytopenia (ITP), in patients at high risk of bleeding or prior to surgery to correct the platelet count,
- Guillain-Barré syndrome,
- Kawasaki disease,
- Chronic inflammatory demyelinating polyneuropathy (CIDP). Only limited experience is available of use of intravenous immunoglobulins in children with CIDP.